Aurora Cannabis Inc.

Overview

1. "How the company got here" Aurora Cannabis was founded in 2006 by Terry Booth and his partners, initially as Milk Capital Corp. before changing its name to Prescient Mining Corp. and finally Aurora Cannabis Inc. in 2014. The company received its first license to grow cannabis in 2014 and to sell medical cannabis later that year, making it an early player in the newly regulated Canadian market. Aurora pursued an aggressive growth strategy through acquisitions, buying companies like CanniMed Therapeutics and MedReleaf for billions of dollars, aiming to become a global leader. This rapid expansion led to a peak valuation of up to $18 billion. However, the company faced significant challenges, including oversupply in the Canadian recreational market and financial losses, leading to restructuring and a shift in focus. 2. "What it actually does" Aurora Cannabis cultivates, produces, and sells a variety of cannabis products. These products include dried flower, cannabis oils, capsules, edibles, and vapes. The company operates in both the medical and adult-use (recreational) cannabis markets. Aurora's products are sold under various brand names and are distributed to medical patients, pharmacies, and licensed cannabis retailers in Canada and internationally. 3. "Medical Cannabis" This segment is a core part of Aurora's business, focusing on providing pharmaceutical-grade cannabis products to patients who use them under medical authorization. These products can include dried flower, oils, and capsules, often recommended by doctors or clinics. Aurora earns revenue by selling these products directly to patients and through distributors and pharmacies that resell them. The company emphasizes its role as a trusted source in medical cannabis, aiming to support Canadians with science-based products. Aurora has a significant international presence in medical cannabis markets, including Europe, Australia, and New Zealand. 4. "Adult-Use Cannabis" Aurora also participates in the legal recreational cannabis market, selling products for adult consumers. This segment includes a range of products such as flower, pre-rolls, vapes, edibles, and oils, marketed under various consumer brands like Drift, San Rafael '71, and Daily Special. Revenue in this segment comes from sales to wholesalers, retailers, and direct online buyers. The company has been expanding its portfolio in this area with innovative recreational products. 5. "Plant Propagation" Aurora has a segment focused on plant propagation, which involves supplying propagated vegetables and ornamental plants. The company holds a controlling interest in Bevo Farms Ltd., a North American supplier in this sector. This business line diversifies Aurora's operations beyond cannabis products. 6. "What management is betting on now" Aurora's current strategy centers on strengthening its position in the global medical cannabis market, emphasizing high-margin international markets and patient care. Management is focused on leveraging its expertise as a large-scale, EU-GMP certified producer to maximize opportunities in what it considers the most attractive and profitable segment of the industry. The company is also investing in modernizing its production facilities with advanced technologies to enhance operational efficiency and reduce costs. Aurora aims to achieve positive cash flow and profitability by optimizing its operations and potentially through strategic partnerships.1. "How the company got here" Aurora Cannabis was founded in 2006 by Terry Booth and his partners, initially as Milk Capital Corp. before changing its name to Prescient Mining Corp. and finally Aurora Cannabis Inc. in 2014. The company received its first license to grow cannabis in 2014 and to sell medical cannabis later that year, making it an early player in the newly regulated Canadian market. Aurora pursued an aggressive growth strategy through acquisitions, buying companies like CanniMed Therapeutics and MedReleaf for billions of dollars, aiming to become a global leader. This rapid expansion led to a peak valuation of up to $18 billion. However, the company faced significant challenges, including oversupply in the Canadian recreational market and financial losses, leading to restructuring and a shift in focus. 2. "What it actually does" Aurora Cannabis cultivates, produces, and sells a variety of cannabis products. These products include dried flower, cannabis oils, capsules, edibles, and vapes. The company operates in both the medical and adult-use (recreational) cannabis markets. Aurora's products are sold under various brand names and are distributed to medical patients, pharmacies, and licensed cannabis retailers in Canada and internationally. 3. "Medical Cannabis" This segment is a core part of Aurora's business, focusing on providing pharmaceutical-grade cannabis products to patients who use them under medical authorization. These products can include dried flower, oils, and capsules, often recommended by doctors or clinics. Aurora earns revenue by selling these products directly to patients and through distributors and pharmacies that resell them. The company emphasizes its role as a trusted source in medical cannabis, aiming to support Canadians with science-based products. Aurora has a significant international presence in medical cannabis markets, including Europe, Australia, and New Zealand. 4. "Adult-Use Cannabis" Aurora also participates in the legal recreational cannabis market, selling products for adult consumers. This segment includes a range of products such as flower, pre-rolls, vapes, edibles, and oils, marketed under various consumer brands like Drift, San Rafael '71, and Daily Special. Revenue in this segment comes from sales to wholesalers, retailers, and direct online buyers. The company has been expanding its portfolio in this area with innovative recreational products. 5. "Plant Propagation" Aurora has a segment focused on plant propagation, which involves supplying propagated vegetables and ornamental plants. The company holds a controlling interest in Bevo Farms Ltd., a North American supplier in this sector. This business line diversifies Aurora's operations beyond cannabis products. 6. "What management is betting on now" Aurora's current strategy centers on strengthening its position in the global medical cannabis market, emphasizing high-margin international markets and patient care. Management is focused on leveraging its expertise as a large-scale, EU-GMP certified producer to maximize opportunities in what it considers the most attractive and profitable segment of the industry. The company is also investing in modernizing its production facilities with advanced technologies to enhance operational efficiency and reduce costs. Aurora aims to achieve positive cash flow and profitability by optimizing its operations and potentially through strategic partnerships.